Acetazolamide Tablet
Product Images NDC 51655-331

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Acetazolamide (NDC 51655-331). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (0c4f0f74 54b9 48c5 837c 022032e507c3 01)

Structure (0c4f0f74 54b9 48c5 837c 022032e507c3 01)
Chemical structure of acetazolamide showing its molecular composition and arrangement of atoms including sulfur, nitrogen, oxygen, and carbon groups characteristic of this active ingredient.*
FDA Label Image

Logo (0c4f0f74 54b9 48c5 837c 022032e507c3 02)

FDA Label Image

Label (51655 331 52 Rev A 03 23)

Label (51655 331 52   Rev A 03 23)
Label for acetazolamide 125 mg tablets, USP, containing 30 tablets. The label indicates prescription-only status and storage instructions between 20°-25°C with permitted excursions. Manufacturer details include repackaging by Northwind Pharmaceuticals and Avet Pharmaceuticals. The label displays the NDC 51655-331-52 and a 2D barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.